Depressive Disorder: all 4,846 studies
Page 46 of 49. Open to participants first (508), then studies with results posted, then the rest; newest registration first within each.
- Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic StimulationCompletedNCT00305045Not applicable
- Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major DepressionCompletedNCT00300404Phase 3
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
- The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECTCompletedNCT00299403Phase 2/3
- Effect of Home-Based Peer Support on Maternal-Infant Interaction and Postpartum DepressionCompletedNCT00298311Not applicable
- Memory Functioning and Antidepressant TreatmentCompletedNCT00296933Phase 3
- Deep Brain Stimulation for Refractory Major DepressionCompletedNCT00296920Phase 3
- Treatment of Depression Following Multiple Brain TestsCompletedNCT00296777Phase 4
- Are Two Antidepressants a Good Initial Treatment for Depression?CompletedNCT00296712Phase 4
- A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
- Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedNCT00296686Phase 4
- The Effectiveness of Idazoxan in Treating TRDWithdrawnNCT00294944Phase 3
- Evaluating the Effectiveness of Brief Interpersonal Psychotherapy for Pregnant Women With DepressionCompletedNCT00292903Not applicable
- Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major DepressionStatus unknownNCT00291239Phase 4
- Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderCompletedNCT00290914Phase 2
- Yoga Breath Program and Client-Centered Exposure for Relief of PTSD in Tsunami VictimsCompletedNCT00290225Phase 3
- EEG Biomarkers for Predicting Response to Antidepressant TherapyCompletedNCT00289523
- A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major DepressionStatus unknownNCT00289484Phase 2
- PET Neuroimaging of [11C]MirtazapineCompletedNCT00288782Phase 4
- Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of DepressionCompletedNCT00287703Phase 3
- Testosterone and Major DepressionCompletedNCT00286546
- Mild Depression 2 Week Observational StudyCompletedNCT00285831
- Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major DepressionCompletedNCT00285766Phase 3
- Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic SettingCompletedNCT00285740Not applicable
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major DepressionCompletedNCT00285727Not applicable
- Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With ResponseCompletedNCT00285376Phase 3
- Lamotrigine in Treatment Resistant Depression in AdolescentsTerminatedNCT00284791Not applicable
- Identification and Therapy of Postpartum DepressionCompletedNCT00282776Phase 3
- Study of Treatments for Depression Among Displaced Adolescents in Northern Uganda.CompletedNCT00280319Not applicable
- Depression and Increased Health Services Utilization Among Elderly Primary Care PatientsCompletedNCT00279526
- Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderCompletedNCT00278941Phase 3
- Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive DisorderCompletedNCT00277823Phase 3
- Lexapro in the Treatment of Patients With Postpartum DepressionCompletedNCT00277108Not applicable
- Aripiprazole Augmentation Therapy in Treatment-resistant DepressionWithdrawnNCT00276978Phase 3
- Bipolar II Depression: Lithium, SSRI, or the CombinationCompletedNCT00276965Phase 3
- Sertraline for the Prevention of Recurrent Postpartum DepressionCompletedNCT00276900Phase 3
- Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled TrialWithdrawnNCT00273624Phase 3
- Treatment Resistant Bipolar DepressionTerminatedNCT00272025Phase 1
- Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research GroupCompletedNCT00265291Phase 2
- GW679769 In FibromyalgiaCompletedNCT00264628
- Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive DisorderWithdrawnNCT00262665Phase 2
- Brain Abnormalities in Late-Onset Major DepressionCompletedNCT00260468
- Genetics of Recurrent Early Onset Major DepressionCompletedNCT00260182
- Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care SettingsCompletedNCT00260169Not applicable
- Comparison of Three Therapy-Based Interventions for Preventing Depression in AdolescentsCompletedNCT00258752Not applicable
- Depression and Transcranial Direct Current Stimulation (tDCS)Status unknownNCT00256438Phase 1/2
- Essential Fatty Acids for Major DepressionCompletedNCT00256412Not applicable
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCompletedNCT00256113Phase 3
- Cognitive Behavioral Therapy for the Treatment of Depression-Related InsomniaCompletedNCT00255905Not applicable
- The Role of Cytokine-Serotonin Interactions in Post-Stroke DepressionCompletedNCT00254020Phase 4
- Depression and Traumatic Brain InjuryCompletedNCT00254007Phase 4
- Venlafaxine Augmentation in Treatment Resistant DepressionCompletedNCT00253266Phase 4
- Early Integrated Intervention in Severe Affective DisordersCompletedNCT00253071Not applicable
- Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderCompletedNCT00252356Phase 3
- Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderCompletedNCT00252330Phase 3
- Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression ScaleStatus unknownNCT00251342Phase 2/3
- A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With DepressionCompletedNCT00250653Phase 3
- An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCompletedNCT00250627Phase 3
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCompletedNCT00250614Phase 3
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCompletedNCT00250601Phase 3
- Accelerated Transcranial Magnetic Stimulation (TMS) for DepressionCompletedNCT00248768Phase 1
- Study Evaluating Venlafaxine Extended Release in Elderly Depressed PatientsCompletedNCT00247429
- Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive DisorderCompletedNCT00247195Not applicable
- Study Evaluating Bifeprunox in Bipolar DepressionCompletedNCT00245973Phase 3
- Patient-Centered Depression Care for African AmericansStatus unknownNCT00243425Not applicable
- Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive DisorderCompletedNCT00242229Not applicable
- Coronary Heart Disease Incidence: Depression & Inflammation RiskCompletedNCT00241774
- Epidemiology of Depression and Heart Failure in AgingCompletedNCT00241761
- Study Evaluating Rhapsody Registry in Patients With Depression and AnxietyCompletedNCT00241397
- Escitalopram Combination Comparison Study for Adult Patients With Major Depressive DisorderStatus unknownNCT00239954Phase 3
- A Study of Omega-3 as a Treatment for Major DepressionStatus unknownNCT00238758Phase 2
- Medications for the Treatment of Dysthymic Disorder and Double DepressionCompletedNCT00234312Phase 4
- Wellbutrin XL, Major Depressive Disorder and Breast CancerCompletedNCT00234195Phase 4
- Investigation of a Combination Treatment of Escitalopram and rTMSCompletedNCT00232700Not applicable
- Treatment of Comorbid Depression and Substance Abuse in Young PeopleCompletedNCT00232284Phase 2
- Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With DepressionTerminatedNCT00232167Phase 3
- Effectiveness of Pramipexole for Treatment-Resistant DepressionCompletedNCT00231959Phase 4
- A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With AnxietyCompletedNCT00229645Phase 4
- Study of Genetic Differences in People With DepressionCompletedNCT00229463
- Estrogen and Perimenopausal DepressionCompletedNCT00229450Phase 4
- Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression DisorderCompletedNCT00229398
- Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's DementiaStatus unknownNCT00229333Phase 4
- Fibromyalgia in Men Suffering From PTSDCompletedNCT00229294
- Effectiveness of Supplemental Calcium in Preventing Postpartum DepressionCompletedNCT00228033Phase 4
- Maintenance Interpersonal Psychotherapy for Sustaining Remission of DepressionCompletedNCT00227981Not applicable
- Comparing Various Treatments for Achieving and Maintaining Remission of DepressionCompletedNCT00227955Phase 4
- Estrogen for Treating Depression in Menopausal Women With Hot Flashes and InsomniaCompletedNCT00227942Phase 4
- Integrated Treatment for Cocaine and Mood Disorders - 1CompletedNCT00227812Phase 2
- Treatment of Mild and Subthreshold Depressive DisordersStatus unknownNCT00226642Phase 4
- Natural Supplements for Unipolar DepressionCompletedNCT00226356Phase 4
- Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.CompletedNCT00225524Phase 3
- Study Evaluating Effexor XR for Major Depression.CompletedNCT00225511Phase 3
- Study Evaluating Effexor XR in Elderly Patients With Major Depression.CompletedNCT00225485Phase 3
- A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using LithiumCompletedNCT00224510Phase 3
- Impact of Caregiver Depression on Asthma in the ChildCompletedNCT00223288
- Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance AbuseCompletedNCT00223197Phase 4
- Depression: The Search for Treatment-Relevant Phenotypes-Pilot StudyCompletedNCT00222820Phase 4
- Can Additional Drug Therapy Accelerate Response Time to AntidepressantsWithdrawnNCT00221494Phase 4
- Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major DepressionStatus unknownNCT00220623Phase 3
- REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSIONStatus unknownNCT00220610Phase 2